Rapamycin for treatment of refractory dysthyroid compressive optic neuropathy

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 3, 2007, Pages 225-226

  Chang, Susie ^a   Perry, Julian D ^a   Kosmorsky, Gregory S ^a   Braun, William E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPA; RAPAMYCIN; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; COLOR; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; HUMAN; HYPERCHOLESTEROLEMIA; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE; VISUAL ACUITY; VISUAL FIELD;

GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NERVE COMPRESSION SYNDROMES; OPTIC NERVE DISEASES; SIROLIMUS; TOMOGRAPHY, X-RAY COMPUTED; VISUAL ACUITY;

EID: 34249059300     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3180500d57     Document Type: Article

References (9)

1. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy. Arch Ophthalmol 2002;120:380-6.
2. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998;31:335-40.
3. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int 2001;59:3-16.
4. Zhu J, Wu J, Frizell E, et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 1999;117:1198-204.
5. Pritchard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 2002;168:942-50.
6. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002;8:128-35.
7. Vrtovsnik F, Couette S, Prie D, et al. Lovastatin-induced inhibition of renal epithelial cell proliferation involves a p21 ras activated, AP-1-dependent pathway. Kidney Int 1997;52:1016-27.
8. Gianoukakis AG, Douglas RS, King CS, et al. Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 2006;147:1941-9.
9. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS. Stimulation of adipogenesis, peroxisome proliferators-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2002;87:2352-8.